Navigation and service

You are here:Risk Assessment Procedures

Methotrexate: European Medicines Agency (EMA) assesses the risk of dosing errors

Date 2018.04.13
Active substance methotrexate

The Federal Institute for Drugs and Medical Devices (BfArM) issues information on the initiation of a safety review by the European Medicines Agency (EMA) to review the risk of dosing errors with methotrexate.

For details on the procedure please click on the following link to the homepage of the European Medicines Agency (EMA):

Methotrexate containing medicinal products